Kingdom Financial Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$458K Sell
1,821
-1,242
-41% -$267K 0.12% 88
2026
Q1
$666K Buy
3,063
+69
+2% +$15.3K 0.19% 56
2025
Q4
$684K Buy
2,994
+2,092
+232% +$477K 0.21% 46
2025
Q3
$209K Buy
+902
New +$184K 0.13% 71
2024
Q1
Sell
-1,648
Closed -$255K 63
2023
Q4
$255K Sell
1,648
-709
-30% -$103K 0.22% 64
2023
Q3
$351K Buy
2,357
+569
+32% +$83.5K 0.33% 46
2023
Q2
$241K Buy
+1,788
New +$262K 0.24% 55

Other funds holding ABBV

Kingdom Financial Group's ABBV Position: Q2 2026 in Review

Kingdom Financial Group reduced its AbbVie (ABBV) stake by 41% in Q2 2026, selling an estimated $267K and leaving 1,821 shares worth $458K. The position accounts for 0.12% of the portfolio, ranked #88.

Kingdom Financial Group first reported a position in ABBV in Q2 2023 and has held it in 7 quarters since. The position peaked at $684K in Q4 2025. 4,218 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Kingdom Financial Group held 1,821 shares of AbbVie worth $458K as of Q2 2026.
  • Kingdom Financial Group sold 1,242 AbbVie shares in Q2 2026, an estimated $267K.
  • AbbVie made up 0.12% of Kingdom Financial Group's portfolio in Q2 2026, its #88 holding.
  • Kingdom Financial Group first reported a position in AbbVie in Q2 2023 and has held it in 7 quarters since.
  • Kingdom Financial Group's AbbVie position peaked at $684K in Q4 2025.
  • 4,218 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Kingdom Financial Group's 13F filing for Q2 2026, filed 7 Aug 2026.